CIK 0001819790
- Large accelerated filer
Tarsus Pharmaceuticals, Inc.
Sign in to watch- Ticker
- TARS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 814717861
- Phone
- +1 949-409-9820
- Business address
- 15440 LAGUNA CANYON ROAD, IRVINE, CA, 92618
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,995,859
- in 7 filings, $6.0M under 10b5-1 plans
Net −$5,995,859. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-15 | Azamian Bobak R. President/CEO and Board Chair | Exercise or conversion | +28,274 | 36,871 | ||
| 2024-03-15 | Azamian Bobak R. President/CEO and Board Chair | Exercise or conversion · Restricted Stock Units | −11,299 | 22,599 | ||
| 2024-03-15 | Azamian Bobak R. President/CEO and Board Chair | Exercise or conversion · Restricted Stock Units | −16,975 | 50,925 | ||
| 2024-03-15 | Whitfield Dianne C. Chief Human Resources Officer | Exercise or conversion | +11,711 | 38,495 | ||
| 2024-03-15 | Whitfield Dianne C. Chief Human Resources Officer | Exercise or conversion · Restricted Stock Units | −4,463 | 8,925 | ||
| 2024-03-15 | Whitfield Dianne C. Chief Human Resources Officer | Exercise or conversion · Restricted Stock Units | −7,248 | 21,745 | ||
| 2024-03-15 | Neervannan Seshadri Chief Operating Officer | Exercise or conversion | +13,245 | 69,646 | ||
| 2024-03-15 | Neervannan Seshadri Chief Operating Officer | Exercise or conversion · Restricted Stock Units | −5,097 | 10,194 | ||
| 2024-03-15 | Neervannan Seshadri Chief Operating Officer | Exercise or conversion · Restricted Stock Units | −8,148 | 24,444 | ||
| 2024-03-07 | Wahl Bryan General Counsel | Grant or award · Stock Option (right to buy) | +42,500 | 42,500 | ||
| 2024-03-07 | Wahl Bryan General Counsel | Grant or award · Restricted Stock Units | +28,702 | 28,702 | ||
| 2024-03-07 | Azamian Bobak R. President/CEO and Board Chair | Grant or award · Stock Option (right to buy) | +136,947 | 136,947 | ||
| 2024-03-07 | Azamian Bobak R. President/CEO and Board Chair | Grant or award · Restricted Stock Units | +92,485 | 92,485 | ||
| 2024-03-07 | Mottiwala Aziz Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +47,500 | 47,500 | ||
| 2024-03-07 | Mottiwala Aziz Chief Commercial Officer | Grant or award · Restricted Stock Units | +32,079 | 32,079 | ||
| 2024-03-07 | Whitfield Dianne C. Chief Human Resources Officer | Grant or award · Stock Option (right to buy) | +42,500 | 42,500 | ||
| 2024-03-07 | Whitfield Dianne C. Chief Human Resources Officer | Grant or award · Restricted Stock Units | +28,702 | 28,702 | ||
| 2024-03-07 | Farrow Jeffrey S | Grant or award · Stock Option (right to buy) | +47,500 | 47,500 | ||
| 2024-03-07 | Farrow Jeffrey S | Grant or award · Restricted Stock Units | +32,079 | 32,079 | ||
| 2024-03-07 | Neervannan Seshadri Chief Operating Officer | Grant or award · Stock Option (right to buy) | +47,500 | 47,500 |
Page 16 of 24 · 469 trades